EUVIMEDEUVIMED entdecken
Crossref

The Impact of Drug Interactions on the Results of DAT-SPECT Imaging in a Specialty Movement Disorders Practice: A Retrospective Analysis of Outcomes

Isabelle Heewon Kang, Danny Bega

Neurodegenerative Diseases · 2024

DOI: 10.1159/000540105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurodegenerative Diseases, 2024. Verfasst von Isabelle Heewon Kang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Tomography, Emission-Computed, Single-Photon, Dopamine Plasma Membrane Transport Proteins, Drug Interactions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

DAT-SPECT imaging is approved as a diagnostic tool for the evaluation of suspected Parkinsonian syndromes, but the FDA-approved package insert lists 16 potential drugs that may interfere with the image obtained. The clinical impact of these drugs on imaging results has not been established. This study aimed to determine the accuracy of DAT-SPECT imaging in assessing presynaptic dopaminergic denervation in the setting of these drugs.

Methods

This is a retrospective chart review of patients at a single center who underwent DAT-SPECT imaging while taking “contraindicated” drugs between December 2012 and December 2022.

Results

A total of 1,224 charts were screened, and 153 (12.5%) charts met the inclusion criteria. Bupropion (32%, n = 49) and sertraline (26%, n = 40) were the most common contraindicated drugs. The false-positive rate was 9.2%.

Conclusion

This retrospective analysis supports the concern that certain drugs may interfere with DAT-SPECT imaging results, leading to potential false positives. This has implications for how clinicians interpret DAT-SPECT imaging in patients taking these medications and whether they should advise patients to stop these medications before a scan is performed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tomography, Emission-Computed, Single-PhotonDopamine Plasma Membrane Transport ProteinsDrug InteractionsHumansRetrospective StudiesMaleFemaleMiddle AgedAgedMovement Disorders

Stichwörter der Autor:innen

DAT-SPECT imagingDopamineMovement disordersParkinsonian disordersParkinson’s disease

Substanzen

Dopamine Plasma Membrane Transport Proteins

Autor:innen und Institutionen

  • Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • The Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Zitieren

APA

Kang, I. H., & Bega, D. (2024). The Impact of Drug Interactions on the Results of DAT-SPECT Imaging in a Specialty Movement Disorders Practice: A Retrospective Analysis of Outcomes. Neurodegenerative Diseases. https://doi.org/10.1159/000540105

Vancouver

Kang IH, Bega D. The Impact of Drug Interactions on the Results of DAT-SPECT Imaging in a Specialty Movement Disorders Practice: A Retrospective Analysis of Outcomes. Neurodegenerative Diseases. 2024. doi:10.1159/000540105

BibTeX
@article{Kang2024,
  author = {Kang, Isabelle Heewon and Bega, Danny},
  title = {The Impact of Drug Interactions on the Results of DAT-SPECT Imaging in a Specialty Movement Disorders Practice: A Retrospective Analysis of Outcomes},
  journal = {Neurodegenerative Diseases},
  year = {2024},
  doi = {10.1159/000540105}
}
Kostenlos starten →